clinical trial · NCT07538622
Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System Registry
Zenflow, Inc.·—·not yet recruiting·n = 300
BPH (Benign Prostatic Hyperplasia)Zenflow Spring System
brief summary
The purpose of this registry is to collect information on how the Zenflow Spring System works in everyday medical practice. The registry will track how the Spring System performs during the implant procedure, and at follow-up visits at 1, 3, 6, and 12 months. We will look at how symptoms improve, how quickly patients return to normal activities, how satisfied they are with treatment, and whether there are any problems or side effects related to the device.
started
Jun 1, 2026
primary completion
Jun 1, 2028
completion
Sep 1, 2028
last updated
Apr 20, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol